WHY GOOD PAIN MANAGEMENT IS GOOD DRUG ABUSE PREVENTION

Size: px
Start display at page:

Download "WHY GOOD PAIN MANAGEMENT IS GOOD DRUG ABUSE PREVENTION"

Transcription

1 WHY GOOD PAIN MANAGEMENT IS GOOD DRUG ABUSE PREVENTION Bob Twillman, Ph.D., FAPM Executive Director Academy of Integrative Pain Management Walking the Tightrope of Pain Management Adverse Events Misuse Death Addiction Diversion Abuse Two Major Public Health Problems Prescription opioid abuse: 12.5 million non-medical users per year $ billion cost per year 16,000-19,000 overdose deaths per year (maybe) Chronic pain: >100 million with chronic pain, ~25-39 million with daily chronic pain, ~10 million disabled $ billion cost per year Suicide risk doubled 42,800 suicide deaths in 2014 ~28,000 were people with chronic pain 1

2 More Commonalities than Differences Prescription drug abuse and chronic pain are more alike than different: Both are highly prevalent Both are very costly, in economic and human terms Both highly stigmatized--patients are blamed Both are poorly understood by the medical profession Both are under-resourced vis-à-vis treatment Both are complex problems, with many moving parts Both best addressed with a biopsychosocial approach Most importantly: Both involve tremendous suffering Not A Zero-Sum Game Often, it feels like any attempt to prevent prescription opioid abuse must be accomplished by reining in prescribing, potentially increasing pain and decreasing function Similarly, it often seems as though any effort to improve pain management must involve increased prescribing, which could, in turn, lead to more adverse outcomes I believe this misstates the case, and that it is possible to address both problems without adversely affecting either by providing balanced pain management A Thought For every complex problem, there is a solution that is neat, simple, and wrong H.L. Mencken I believe that implementing overly simplistic policy solutions for these two very complex problems leads to the zero-sum game that we so often perceive Perhaps the solutions we should be seeking are as complex as the problems we are trying to solve 2

3 Overdose Deaths Involving Prescription Opioids Statistics are somewhat squishy due to Coding, and counting, multiple causes of death for one decedent Difficulty distinguishing between parent drug and metabolites Difficulty distinguishing between licit and illicit forms of the same drug, especially fentanyl Overdose Deaths Involving Prescription Opioids Overdose Deaths Involving Opioids 3

4 Overdose Deaths Involving Prescription Opioids Most are poly-substance overdoses: Previous CDC research suggests that about 75-80% of decedents used multiple drugs, not including alcohol Among drug overdose decedents in Florida in the first half of 2013, the state medical examiners network reported that 93.5% had multiple drugs on board Most decedents don t have active prescriptions: Two studies (one from CDC) show that as many as 55-60% did not have an active prescription for the drugs involved Recent research in Massachusetts revealed that only 8% of decedents had active prescriptions We need much better understanding of what these numbers mean, so we can craft better solutions Filtering the Noise to Find the Signal One key task in statistics is reducing or eliminating the noise to detect the true signal Drug overdose data have always been pretty noisy, but the static is increasing Detecting the true signal is very challenging What s happening to prescription drug abuse rates? Increasing? Stable? Decreasing? 4

5 How Do We Explain This? Rx Opioid OD Deaths Rx Opioid OD Deaths NSDUH data: Non-medical use, opioid use disorder rates (%) in people > 12 years old Past Yr NMU Past Year OUD Asking the Right Questions To get the right answers, we have to ask the right questions The Right Question about Opioids for Chronic Pain The wrong question is, Should we use opioids to treat chronic pain? The right question is, In which patients should we use opioids, at what doses, for how long, with which adjunctive treatments, and with what precautions? 5

6 Pathways to Prevention Findings In September 2014, NIH sponsored a two-day Pathways to Prevention workshop on The Role of Opioids in the Treatment of Chronic Pain Extensive evidence review was carried out prior to the meeting After the meeting, an unbiased panel developed a report regarding the risks and benefits of using opioids to treat chronic pain The key conclusion: What was particularly striking to the panel was the realization that there is insufficient evidence for every clinical decision that a provider needs to make regarding the use of opioids for chronic pain, leaving the provider to rely on his or her own clinical experience. Question: If that s the case, then how do we find our way out of the mess we re in? Revisiting the Role of Opioids for Chronic Pain Careful, judicious use of opioids with both pain relief and patient safety in mind is appropriate in pain management. Opioids are necessary, but we need other tools as well: Within the context of an integrative model of care, the Academy recognizes the effectiveness of opioids as part of a comprehensive treatment plan for some people who experience chronic pain. When prescribed judiciously by clinicians who are well educated about prescribing these medications, and taken as directed by patients who are well informed about these medications, opioids may be useful in reducing pain and restoring function. Appropriate Treatment for Chronic Pain Appropriate treatment for chronic pain is multimodal, including interventions like exercise, nutrition, integrative medicine treatments, medications not just opioids, because there may be others that work better This kind of treatment focuses primarily on improving function, rather than focusing totally on pain intensity Use of multiple types of treatment should reduce reliance on opioid analgesics as a primary means of treating pain Multiple barriers exist to providing this type of care for chronic pain 6

7 Appropriate Treatment for Chronic Pain (cont.) If all you have is a hammer, every problem looks like a nail. Abraham Maslow The biopsychosocial model recognizes the need to use multiple tools to fix the broken system that results in chronic pain Unfortunately, the system that provides those tools also is broken. We need more tools, and better access to the tools we have. This requires: More basic medical education content for traditional students Extensive continuing education for licensed providers Available providers of non-medication treatments Access to referral networks for those providers Adequate reimbursement for those providers Guidelines for Treating Chronic Pain Increasingly, we are seeing governmental agencies issue guidelines for the treatment of chronic pain The focus of these guidelines tends to be heavily on appropriate use of opioids in this setting ALL of these guidelines are based, almost entirely, on expert opinion Guideline issued on March 15, 2016 by the CDC is a prime example Good Evidence is Lacking Remember the Pathways to Prevention expert panel statement: What was particularly striking to the panel was the realization that there is insufficient evidence for every clinical decision that a provider needs to make regarding the use of opioids for chronic pain, leaving the provider to rely on his or her own clinical experience. 7

8 Good Evidence is Lacking Lack of evidence rarely inhibits policymakers who see an opportunity Legislating the CDC Guideline: Dose Limits Rhode Island H 8224: Limits opioids for acute pain to no more than 30 MME/day for a maximum of 20 doses Maine: 300 MME/day maximum dose initially; as of 7/1/17, 100 MME/day maximum dose; no more than a 30- day supply in a 30-day period for chronic pain; no more than a 7-day supply in a 7-day period for acute pain Exceptions: Active and aftercare cancer treatment, palliative care, end-of-life and hospice care, MAT for SUD, or other circumstances by rule Similar legislation introduced in Pennsylvania and Michigan Legislating the CDC Guideline s Acute Pain Recommendation: DC 15-Day Limit 10-Day Limit 7-Day Limit 5-Day Limit 3-Day Limit 8

9 ACUTE PAIN Excess Supplies of Opioids in Acute Pain Prescriptions for acute pain have also been noted by some as the source of excess opioid doses One case example will illustrate this point; many people have similar stories Acute Pain Management Case 53 y/o female has arthroscopic knee surgery for partial medial meniscectomy. Patient has a history of adverse reaction to hydrocodone/ APAP (full body rash). The surgeon prescribed oxycodone/apap, along with an NSAID and an ice machine. 9

10 Acute Pain Management Case Here is how much oxycodone/apap was actually used by the patient: Acute Pain Management Case Here is how much oxycodone/apap was left over: Why Does This Happen??!? Surgeons are doing what they learned to do in their training They are motivated to ensure that their patients have adequate pain relief They have a hard time accommodating patients who run out of medication, so they prescribe as if every patient uses as much as the patient at the 99 th percentile Note that hydrocodone rescheduling may be exacerbating this Partial fill legislation may alleviate this They may not know the 50 th percentile, or median, dose 10

11 The Right Question about Prescription Opioid Supplies How can we reduce the supply of prescription opioids? is the wrong question The right question is, How can we reduce the EXCESS supply of prescription opioids? How do we define excess? Data on Prescribing for Surgical Pain Hill et al., 2017, Annals of Surgery Studied opioids prescribed for five common outpatient surgeries Surveyed patients to determine how much of prescribed medication was used Calculated the number of pills needed to supply the needs of 80% of patients Calculated potential pill savings if this number was prescribed Data on Prescribing for Surgical Pain Surgery Median Rx d Range Rx d Percent Taken 80th %ile Partial Mastectomy Partial Mastectomy + Sentinel LN Biopsy Laparoscopic Cholecystectomy Lap Inguinal Hernia Repair Open Inguinal Hernia Repair N = 642; if 80 th percentile amount was prescribed, would save 9,787 pills 11

12 Data on Prescribing for Surgical Pain In a follow-up study, authors educated surgeons about their findings, and encouraged use of NSAID/ acetaminophen Mean number of pills prescribed decreased: PM: from 19.8 to 5.1 PM+SLNB: from 23.7 to 9.6 Lap Chole: from 35.2 to 19.4 Lap Ing Hernia: from 33.8 to 19.3 Open Ing Hernia: from 33.2 to 18.3 Overall, 53% decrease in pills prescribed Only 1 of 246 patients in study needed a refill Other Possible Solutions Conduct a PDMP check prior to discharge, so that patients with medications already at home are taught how to use them appropriately, rather than dispensing a new excess supply Allow partial fills of prescriptions, with remainder still available if needed CARA bill allows this at the federal level DEA is writing regulations to enact this law Some state laws will need to be changed to allow this Patient Safety Best Practices Pursue a balanced, multi-disciplinary approach to providing pain care Individualize treatment plans for each person with pain there is no cookbook, and one size doesn t even fit most Decrease opioid prescribing by incorporating multimodal analgesia Emphasize proper use, storage, and disposal; educate people with pain, family members, other loved ones and caregivers 12

13 A Final Word Medical professionals, especially those specializing in pain management, want to be part of the solution that enables us to provide pain care that is both safe and effective In part, we need to better use some tools we already have In part, we need some additional tools to effectively treat both acute and chronic pain in ways that don t exacerbate prescription drug abuse and other adverse outcomes We need to assert our appropriate role in developing solutions that promote balanced pain management, on behalf of ourselves and the people with pain for whom we care Thank you for your attention 13

OPIOID RISK ASSESSMENT IN CANCER PATIENTS. Bob Twillman, Ph.D., FAPM Executive Director Academy of Integrative Pain Management

OPIOID RISK ASSESSMENT IN CANCER PATIENTS. Bob Twillman, Ph.D., FAPM Executive Director Academy of Integrative Pain Management OPIOID RISK ASSESSMENT IN CANCER PATIENTS Bob Twillman, Ph.D., FAPM Executive Director Academy of Integrative Pain Management Walking the Tightrope of Pain Management Adverse Events Misuse Suicide Death

More information

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division The Oregon Opioid Initiative State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division Disclosure No disclosures 2 Learning Objectives Learner will be able

More information

Opioid Review and MAT Clinic CDC Guidelines

Opioid Review and MAT Clinic CDC Guidelines 1 Opioid Review and MAT Clinic CDC Guidelines January 10, 2018 Housekeeping Use chat feature to inform everyone who s at your clinic Click chat on Zoom option bar Chat Everyone the names of those who are

More information

Appropriate Opioid Prescribing for Acute Pain after Surgery

Appropriate Opioid Prescribing for Acute Pain after Surgery Appropriate Opioid Prescribing for Acute Pain after Surgery Richard J. Barth Jr. Professor of Surgery Chief, Section of General Surgery Dartmouth Hitchcock Medical Center Clinical Trials Network Webinar

More information

Reversing America s Opioid Epidemic. August 2017

Reversing America s Opioid Epidemic. August 2017 Reversing America s Opioid Epidemic August 2017 Goals of presentation Discuss national and regional opioid-related mortality and prescribing trends Highlight national and state legislative and other policy

More information

OPIOID PRESCRIBING RULES. May 17, 2017 Webinar

OPIOID PRESCRIBING RULES. May 17, 2017 Webinar OPIOID PRESCRIBING RULES May 17, 2017 Webinar Outline Introduction and Universal Precautions Dr. Levine, Commissioner, Health Department 15 Minutes Acute Pain Dr. Patti Fisher, UVMMC 20 Minutes Chronic

More information

The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin Epidemic in our Country

The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin Epidemic in our Country Integrating Primary and Behavioral Health Care Through the Lens of Prevention July 14, 2016 New Orleans, Louisiana The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin

More information

The 86 th Texas Legislature s Policy Response to Opioids Prepared by the Texas Orthopaedic Association

The 86 th Texas Legislature s Policy Response to Opioids Prepared by the Texas Orthopaedic Association The 86 th Texas Legislature s Policy Response to Opioids Prepared by the Texas Orthopaedic Association The United States is in the midst of an epidemic of substance misuse and abuse that applies to all

More information

Michael M. Miller, MD, FASAM, FAPA

Michael M. Miller, MD, FASAM, FAPA Michael M. Miller, MD, FASAM, FAPA mmiller@rogershospital.org Medical Director, Herrington Recovery Center (HRC) Rogers Memorial Hospital Oconomowoc, Wisconsin Vice Speaker Wisconsin Medical Society Clinical

More information

Appropriate Opioid Prescribing for Acute Pain after Surgery

Appropriate Opioid Prescribing for Acute Pain after Surgery Appropriate Opioid Prescribing for Acute Pain after Surgery Richard J. Barth Jr. Professor of Surgery Chief, Section of General Surgery Dartmouth Hitchcock Medical Center American Urologic Association

More information

October 15, Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852

October 15, Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 Re: Docket No. FDA-2012-N-0548 To Whom It May Concern: The American Dental Association

More information

Changing Prescribing Practices In Dentistry

Changing Prescribing Practices In Dentistry Changing Prescribing Practices In Dentistry Paul J. Desjardins, D.M.D., Ph.D. Adjunct Clinical Professor, Rutgers School of Dental Medicine Visiting Professor, Tufts University, School of Dental Medicine

More information

STATEMENT. of the. American Medical Association. for the Record. House Committee on Energy and Commerce

STATEMENT. of the. American Medical Association. for the Record. House Committee on Energy and Commerce STATEMENT of the American Medical Association for the Record House Committee on Energy and Commerce RE: Federal Efforts to Combat the Opioid Crisis: A Status Update on CARA and Other Initiatives October

More information

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE September 20, 2013 Association of State and Territorial Health Officials Annual Meeting R. Gil Kerlikowske Director of National Drug Control Policy National

More information

Aligning Market Objectives and Policy for National Public Health

Aligning Market Objectives and Policy for National Public Health Abuse-Deterrent Formulations Summit March 7, 2017 Alexandria, Virginia Aligning Market Objectives and Policy for National Public Health Shruti Kulkarni, Esq. Outside Counsel Twitter: @claad_coalition CLAAD

More information

Potential Solutions to Epidemic Substance Abuse in US and Europe

Potential Solutions to Epidemic Substance Abuse in US and Europe Potential Solutions to Epidemic Substance Abuse in US and Europe Richard C. Dart, MD, PhD Director, Rocky Mountain Poison and Drug Center, Denver Health 1 Professor, University of Colorado School of Medicine

More information

Effect of Abuse-Deterrent Formulations and IR Opioids on Abuse, Overdose and Death from Rx Opioids

Effect of Abuse-Deterrent Formulations and IR Opioids on Abuse, Overdose and Death from Rx Opioids Effect of Abuse-Deterrent Formulations and IR Opioids on Abuse, Overdose and Death from Rx Opioids Richard C. Dart, MD, PhD Executive Director, RADARS System Professor, University of Colorado Competing

More information

Pennsylvania Prescription Drug Monitoring Program Trends,

Pennsylvania Prescription Drug Monitoring Program Trends, DEA Intelligence Report Brief DEA-PHL-DIR-006-17 Pennsylvania Prescription Drug Monitoring Program Trends, 2014-2015 December 2016 1 Executive Summary The abuse and diversion of pharmaceutical drugs, particularly

More information

Prescription Drug Abuse:

Prescription Drug Abuse: Prescription Drug Abuse: Regulatory Considerations Robert J. Burns Manager, Legislative and Regulatory Policy 202-789-5176 burnsr@ada.org Examining Prescription Drug Abuse Conference Call Prescription

More information

July 6, Scott Gottlieb, MD Commissioner U.S. Food and Drug Administration New Hampshire Avenue Silver Spring, MD 20993

July 6, Scott Gottlieb, MD Commissioner U.S. Food and Drug Administration New Hampshire Avenue Silver Spring, MD 20993 Scott Gottlieb, MD Commissioner U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 RE: Draft Revisions to the Food and Drug Administration Blueprint for Prescriber Education

More information

New Guidelines for Prescribing Opioids for Chronic Pain

New Guidelines for Prescribing Opioids for Chronic Pain New Guidelines for Prescribing Opioids for Chronic Pain Andrew Lowe, Pharm.D. CAPA Meeting October 6, 2016 THE EPIDEMIC Chronic Pain and Prescription Opioids 11% of Americans experience daily (chronic)

More information

The Challenge of Treating Pain

The Challenge of Treating Pain FDA Charge to the Committee: FDA Opioid Action Plan and Incorporating the Broader Public Health Impact into the Formal Risk-Benefit Assessment for Opioids Robert M. Califf, MD Commissioner of Food and

More information

Prescription Drug Abuse National Perspective

Prescription Drug Abuse National Perspective Prescription Drug Abuse National Perspective Timothy P. Condon, Ph.D. Science Policy Advisor Office of the Director White House Office of National Drug Control Policy Commonly Abused Prescription Drugs

More information

Integrated Care Approach to Chronic Pain. David Charles, MD

Integrated Care Approach to Chronic Pain. David Charles, MD Integrated Care Approach to Chronic Pain David Charles, MD David Charles, M.D. Chairman, Alliance for Patient Access Professor and Vice-Chair of Neurology Vanderbilt University Medical Center Chief Medical

More information

Rule Governing the Prescribing of Opioids for Pain

Rule Governing the Prescribing of Opioids for Pain Rule Governing the Prescribing of Opioids for Pain 1.0 Authority This rule is adopted pursuant to Sections 14(e) and 11(e) of Act 75 (2013) and Sections 2(e) and 2a of Act 173 (2016). 2.0 Purpose This

More information

CDC Guideline for Prescribing Opioids for Chronic Pain. Centers for Disease Control and Prevention National Center for Injury Prevention and Control

CDC Guideline for Prescribing Opioids for Chronic Pain. Centers for Disease Control and Prevention National Center for Injury Prevention and Control CDC Guideline for Prescribing Opioids for Chronic Pain Centers for Disease Control and Prevention National Center for Injury Prevention and Control THE EPIDEMIC Chronic Pain and Prescription Opioids 11%

More information

Implementation: Public Hearing: Request for Comments (FDA-2017-N-6502)

Implementation: Public Hearing: Request for Comments (FDA-2017-N-6502) March 16, 2018 via online submission: www.regulations.gov The Honorable Scott Gottlieb Commissioner Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 Re: Opioid Policy Steering

More information

11/11/2015. MVAs Suicide Firearms Homicide. Where Can I Find A Copy of the PDMP Law? Why Was the Law Established? Why Was the Law Established?

11/11/2015. MVAs Suicide Firearms Homicide. Where Can I Find A Copy of the PDMP Law? Why Was the Law Established? Why Was the Law Established? Where Can I Find A Copy of the PDMP Law? Alabama Uniform Controlled Substances Act Code of Alabama 1975 20-2- (Article 10) -210 through 220 and Rules 420-7-2-.11 through.13 1 Why Was the Law Established?

More information

Morrison County Community-Based Care Coordination. Our Core Values Reverence Integrity Compassion Excellence

Morrison County Community-Based Care Coordination. Our Core Values Reverence Integrity Compassion Excellence Morrison County Community-Based Care Coordination Our Core Values Reverence Integrity Compassion Excellence Community Based Care Coordination Project The goal is to mitigate the need for, overuse of, and

More information

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse Pain, Pain Management and the Opioid Epidemic Symposium Jill M Williams, MD Professor Psychiatry Director, Division Addiction

More information

American Academy of Pain Medicine American Pain Society American Society of Anesthesiologists

American Academy of Pain Medicine American Pain Society American Society of Anesthesiologists PAIN CARE COALITION A National Coalition for Responsible Pain Care American Academy of Pain Medicine American Pain Society American Society of Anesthesiologists August 29, 2017 The Honorable Chris Christie,

More information

Improving Opioid Stewardship Amidst an Opioid Crisis

Improving Opioid Stewardship Amidst an Opioid Crisis Improving Opioid Stewardship Amidst an Opioid Crisis Jonah Stulberg, MD PhD FACS PANC/POSSE Webinar October 18, 2018 Disclosures Jonah J Stulberg is the Principal Investigator (PI) on the following grants:

More information

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville Trends and Challenges: The Kentucky Opioid Crisis Jason Smith, MD PhD University of Louisville Brief Introduction I am by no means an expert I have no financial disclosures Jokes are meant to be lighthearted

More information

5 A s Opioid therapy monitoring tool

5 A s Opioid therapy monitoring tool 5 A s Opioid therapy monitoring tool Once initiating opioid therapy, it should be monitored regularly by assessing what has been called the 5As of Analgesia therapy. This monitoring tool, will assist you

More information

Pain Care & Prescription Drug Abuse: Current Topics, Legislation & Policy. Disclosure. Preview

Pain Care & Prescription Drug Abuse: Current Topics, Legislation & Policy. Disclosure. Preview Providers Clinical Support System for Opioid Therapies (PCSS-O) Webinar March 7, 2017 Pain Care & Prescription Drug Abuse: Current Topics, Legislation & Policy Wade Delk, Government Affairs Director, ASPMN

More information

Strategies for Federal Agencies

Strategies for Federal Agencies Confronting Pain Management and the Opioid Epidemic Strategies for Federal Agencies Over the past 25 years, the United States has experienced a dramatic increase in deaths from opioid overdose, opioid

More information

The Role of Dentists in Preventing Opioid Abuse Tufts Health Care Institute Program on Opioid Risk Management 12 th Summit Meeting March 11-12, 2010

The Role of Dentists in Preventing Opioid Abuse Tufts Health Care Institute Program on Opioid Risk Management 12 th Summit Meeting March 11-12, 2010 The Role of Dentists in Preventing Opioid Abuse Tufts Health Care Institute Program on Opioid Risk Management 12 th Summit Meeting March 11-12, 2010 EXECUTIVE SUMMARY It is well documented in multiple

More information

California. Prescribing and Dispensing Profile. Research current through November 2015.

California. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile California Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

EXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS

EXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS EXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS Gina M. Raimondo, Governor Nicole Alexander-Scott, MD, MPH, Director of Health Action Plan Strategies to Date Since 2015, we

More information

Public Health Federal Funding Request to Address the Opioid Epidemic

Public Health Federal Funding Request to Address the Opioid Epidemic Public Health Federal Funding Request to Address the Opioid Epidemic On December 4, 2017, in response to the President s recent declaration of the opioid epidemic as a public health emergency and the final

More information

Opioid Prescribing Tips & Tricks CANDY STOCKTON, MD MAY 2018

Opioid Prescribing Tips & Tricks CANDY STOCKTON, MD MAY 2018 Opioid Prescribing Tips & Tricks CANDY STOCKTON, MD MAY 2018 Disclosures None Educational Objectives Understand CA state medical board guidelines for prescribing opioids for chronic pain Understand the

More information

Preventing Prescription Opioid Misuse Among Student Athletes

Preventing Prescription Opioid Misuse Among Student Athletes Preventing Prescription Opioid Misuse Among Student Athletes Massachusetts is in the midst of an opioid epidemic. Athletes in particular, due to their risk of injury and the resulting pain, may be at risk

More information

Battling Opioid Addiction: Public Policy and Healthcare Strategies for an Epidemic

Battling Opioid Addiction: Public Policy and Healthcare Strategies for an Epidemic Battling Opioid Addiction: Public Policy and Healthcare Strategies for an Epidemic Speakers: Margarita Pereyda, M.D., Principal, Moderator: Carl Mercurio, Information Services September 29, 2015 HealthManagement.com

More information

High-Decile Prescribers: All Gain, No Pain?

High-Decile Prescribers: All Gain, No Pain? High-Decile Prescribers: All Gain, No Pain? Len Paulozzi, MD, MPH National Center for Injury Prevention and Control Centers for Disease Control and Prevention National Center for Injury Prevention and

More information

Opioid Use and Other Trends

Opioid Use and Other Trends Opioid Use and Other Trends National Overview Across the nation communities are struggling with a devastating increase in the number of people misusing opioid drugs, leading many to identify the current

More information

Our Core Thoughts on Dealing with the Opioid Addiction Crisis. Meghan McNelly, PharmD, MHA, FACHE Suzette Song, MD Joseph Alhadeff, MD

Our Core Thoughts on Dealing with the Opioid Addiction Crisis. Meghan McNelly, PharmD, MHA, FACHE Suzette Song, MD Joseph Alhadeff, MD Our Core Thoughts on Dealing with the Opioid Addiction Crisis Meghan McNelly, PharmD, MHA, FACHE Suzette Song, MD Joseph Alhadeff, MD Outline Brief History of the Opioid Problem How did we as a medical

More information

Key Findings and Recommendations from the

Key Findings and Recommendations from the June 2014 Improving Community Health Through Policy Research Key Findings and Recommendations from the 2013 IPLA INSPECT Knowledge and Use Survey 2014 Center for Health Policy (14-H54) IU Richard M Fairbanks

More information

Removing the Stigma from Substance Use Disorder. Joan Duwve, MD, MPH Associate Dean for Practice Richard M. Fairbanks School of Public Health

Removing the Stigma from Substance Use Disorder. Joan Duwve, MD, MPH Associate Dean for Practice Richard M. Fairbanks School of Public Health Removing the Stigma from Substance Use Disorder Joan Duwve, MD, MPH Associate Dean for Practice Richard M. Fairbanks School of Public Health Learning Objectives Recognize the impact of Stigma on getting

More information

Rhode Island. Prescribing and Dispensing Profile. Research current through November 2015.

Rhode Island. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Rhode Island Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC

EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC RAMI R KHOURY, MD, FACEP ASSISTANT MEDICAL DIRECTOR EMERGENCY CARE ALLEGIANCE HEALTH ADVERTISING AT ITS BEST! OVERDOSE

More information

I. Chronic Pain Information Page 2-3. II. The Role of the Primary Care Physician in Chronic Pain Management Page 3-4

I. Chronic Pain Information Page 2-3. II. The Role of the Primary Care Physician in Chronic Pain Management Page 3-4 SUTTER MEDICAL FOUNDATION (SMF) 2750 GATEWAY OAKS DRIVE, #150 SACRAMENTO, CA 95833 SPA PCP Treatment & Referral Guidelines PAIN MANAGEMENT Developed June 1, 2003 Revised (Format Revisions) November 13,

More information

Working with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m.

Working with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m. Working with People Who Use Drugs in HIV Care Settings August 29, 2017 Workshop C 2:00 3:30 p.m. Working with People Who Use Drugs in HIV Care Settings Facilitator: Liz Hall, CDPH Office of AIDS Matt Curtis,

More information

Opioid Task Force Kick-Off Meeting. February 29, 2016

Opioid Task Force Kick-Off Meeting. February 29, 2016 Opioid Task Force Kick-Off Meeting February 29, 2016 Scope of the Opioid Problem and Data Review Olivia Kasirye, MD, MS County Public Health Officer OVERVIEW The Opioid Epidemic Opioid Task Force Development

More information

The Opioid Crisis: Effectiveness of State Responses

The Opioid Crisis: Effectiveness of State Responses The Opioid Crisis: Effectiveness of State Responses Gordon H. Smith, Esq. Maine Medical Association American Society of Medical Association Counsel Mauna Lani Bay, November 2017 Opioids: the difficult

More information

Opioid Management of Chronic (Non- Cancer) Pain

Opioid Management of Chronic (Non- Cancer) Pain Optima Health Opioid Management of Chronic (Non- Cancer) Pain Guideline History Original Approve Date 5/08 Review/Revise Dates 11/09, 9/11, 9/13, 09/15, 9/17 Next Review Date 9/19 These Guidelines are

More information

The Opioid Epidemic: What is the Role of Acute Pain Prescribing?

The Opioid Epidemic: What is the Role of Acute Pain Prescribing? The Opioid Epidemic: What is the Role of Acute Pain Prescribing? How did we get here? 2012: 259 million opioid prescriptions 40% : Levy B, Paulozzi L, Mack KA, Jones CM. Trends in Opioid Analgesic-Prescribing

More information

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable Arizona Amends worker s compensation statute to require physicians to request PMP information within two (2) business days of writing or dispensing prescriptions for at least a 30 day supply of an opioid

More information

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION HOUSE BILL DRH20012-MGfa-35H* (01/26)

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION HOUSE BILL DRH20012-MGfa-35H* (01/26) H GENERAL ASSEMBLY OF NORTH CAROLINA SESSION HOUSE BILL DRH0-MGfa-H* (01/) H.B. Mar, HOUSE PRINCIPAL CLERK D Short Title: Strengthen Opioid Misuse Prevention (STOP)Act. (Public) Sponsors: Referred to:

More information

Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

Virginia. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Michigan Opioid Legislation Hospital Compliance Checklist

Michigan Opioid Legislation Hospital Compliance Checklist MHA KEYSTONE CENTER MICHIGAN OPIOID LEGISLATION HOSPITAL COMPLIANCE CHECKLIST The Michigan Opioid Legislation was created by the Michigan Health & Hospital Association to help guide its member hospitals

More information

Minnesota. Prescribing and Dispensing Profile. Research current through November 2015.

Minnesota. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Minnesota Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Do you CARA? A Deep Dive Into the Comprehensive Addiction and Recovery Act Joel White, President

Do you CARA? A Deep Dive Into the Comprehensive Addiction and Recovery Act Joel White, President Do you CARA? A Deep Dive Into the Comprehensive Addiction and Recovery Act Joel White, President AGENDA 01 03 05 07 By The Numbers PDMPs in CARA Action Since Enactment Questions? 02 CARA Basics 04 What

More information

House Committee on Energy and Commerce House Committee on Energy and Commerce. Washington, DC Washington, DC 20515

House Committee on Energy and Commerce House Committee on Energy and Commerce. Washington, DC Washington, DC 20515 February 28, 2018 The Honorable Michael Burgess, M.D. The Honorable Gene Green Chairman Ranking Member Subcommittee on Health Subcommittee on Health House Committee on Energy and Commerce House Committee

More information

The Difficult Patient: Risk Mitigation Strategies

The Difficult Patient: Risk Mitigation Strategies The Difficult Patient: Risk Mitigation Strategies C. Scott Anthony, D.O. Pain Management of Tulsa 1 Opioid Backlash National emergency Opioids not indicated for chronic pain Forces pushing for reduction

More information

Update: How the CDC Guidelines Are Impacting Patient Care

Update: How the CDC Guidelines Are Impacting Patient Care Update: How the CDC Guidelines Are Impacting Patient Care Stephen J. Ziegler, PhD, JD Disclosures Nothing to disclose 1 Learning Objectives Describe the opioid prescribing guideline created by the CDC

More information

ScO.S. Academic Detailing for Safer Prescribing

ScO.S. Academic Detailing for Safer Prescribing ScO.S. Academic Detailing for Safer Prescribing Sarah Ball, PharmD Research Assistant Professor MUSC College of Medicine September 6, 2017 Megan Pruitt, PharmD SCORxE Clinical Pharmacy Consultant MUSC

More information

Strategies to Manage The Opioid Crisis

Strategies to Manage The Opioid Crisis Strategies to Manage The Opioid Crisis Matt Feehery, LCDC Senior Vice President & CEO PaRC (Prevention & Recovery Center) Behavioral Health Services February 1, 2018 A Pill for Your Pain But my doctor

More information

Legal Issues in Opioid Prescribing

Legal Issues in Opioid Prescribing Legal Issues in Opioid Prescribing Joanne L. Martin, J.D. Legal Counsel Mayo Clinic Rochester, Mn 2015 MFMER slide-1 Conflict of Interest I have no relevant financial relationships to disclose I will not

More information

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable Arizona Amends worker s compensation statute to require physicians to request PMP information within two (2) business days of writing or dispensing prescriptions for at least a 30 day supply of an opioid

More information

Policy and Political Dynamics of the Opioid Addiction Crisis in the United States

Policy and Political Dynamics of the Opioid Addiction Crisis in the United States Policy and Political Dynamics of the Opioid Addiction Crisis in the United States Mark W. Parrino, M.P.A. July 21, 2018 15 th Annual Midwest Conference on Problem Gambling and Substance Abuse Hilton Kansas

More information

Establishment of an Opioid Stewardship Program. Cindy Williams, BS Pharm, FASHP VP/Chief Pharmacy Officer Riverside Health System

Establishment of an Opioid Stewardship Program. Cindy Williams, BS Pharm, FASHP VP/Chief Pharmacy Officer Riverside Health System Establishment of an Opioid Stewardship Program Cindy Williams, BS Pharm, FASHP VP/Chief Pharmacy Officer Riverside Health System Disclosure I have no relevant financial relationships to disclose. Learning

More information

The Prescription Opioid and Heroin Crisis

The Prescription Opioid and Heroin Crisis The Prescription Opioid and Heroin Crisis Dr. Rachel L. Levine Acting Secretary of Health and Physician General Professor of Pediatrics and Psychiatry Penn State College of Medicine Overdose deaths from

More information

SC MAT ACCESS. Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC

SC MAT ACCESS. Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC SC MAT ACCESS Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC Overdose Death Rates from Opiates Most important sign of a

More information

The Opioid Crisis Made in America Fade in America?

The Opioid Crisis Made in America Fade in America? The Opioid Crisis Made in America Fade in America? The President s Commission On Combating Drug Addiction and the Opioid Crisis Bertha K Madras, PhD Professor of Psychobiology Department of Psychiatry

More information

A LOOK AT ABUSE-DETERRENT OPIOIDS

A LOOK AT ABUSE-DETERRENT OPIOIDS JULY 2017 Drugs Under Review ICER s report reviewed evidence on ten abuse-deterrent formulations (ADF) of opioids. Nine of the drugs were extended release (ER) opioids, and one was immediate release (IR).

More information

Hydrocodone Combination Analgesic Products Clinical Impact of a Schedule Change

Hydrocodone Combination Analgesic Products Clinical Impact of a Schedule Change Hydrocodone Combination Analgesic Products Clinical Impact of a Schedule Change Frederick A. Curro D.M.D., Ph.D. Director, PEARL Practice Based Research Network Director, Regulatory Affairs, Bluestone

More information

Best Practices and Foundation Forum. Fred Wells Brason II

Best Practices and Foundation Forum. Fred Wells Brason II Best Practices and Foundation Forum Fred Wells Brason II fbrason@projectlazarus.org Wilkes County, NC Manual labor dominates employment options in this county of 69,000. Wilkes 4 Marvelous M s Moonshine

More information

Evidence-Based Postoperative Opioid Prescribing Guidelines

Evidence-Based Postoperative Opioid Prescribing Guidelines Evidence-Based Postoperative Opioid Prescribing Guidelines PA NSQIP Consortium October 18, 2018 Thomas Farley, MD, MPH Commissioner Philadelphia Department of Public Health Evidence-Based Postoperative

More information

University of Pittsburgh

University of Pittsburgh Learning Objectives Participants will be able to: Associate the history of prescription drug use in America with the current trend of prescription drug abuse; Differentiate between the three most commonly

More information

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. 2017 State Targeted Response to the Opioid Crisis Grants QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. H.R.6-21st Century Cures Act The 21st Century Cures Act is a United States law enacted

More information

Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse

Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse Jay Butler, MD, President of ASTHO, Chief Medical Officer, Alaska Department of Health

More information

Resist the Opioid Pendulum: Understanding Opioids and Pain, and how they relate to Addiction

Resist the Opioid Pendulum: Understanding Opioids and Pain, and how they relate to Addiction Resist the Opioid Pendulum: Understanding Opioids and Pain, and how they relate to Addiction Stefan G. Kertesz, MD, MSc Diplomate, American Board of Addiction Medicine Associate Professor, University of

More information

Aniston's 'Cake' shines a light on Rx drug abuse epidemic

Aniston's 'Cake' shines a light on Rx drug abuse epidemic Aniston's 'Cake' shines a light on Rx drug abuse epidemic Used properly, prescription drugs cure disease, improve the lives of people who suffer from chronic conditions, or ease the pain and suffering

More information

Interventions in Prescription Opioid Abuse Do (or can) Prescription Monitoring Programs Make a Difference?

Interventions in Prescription Opioid Abuse Do (or can) Prescription Monitoring Programs Make a Difference? Interventions in Prescription Opioid Abuse Do (or can) Prescription Monitoring Programs Make a Difference? Richard C. Dart, MD, PhD Executive Director of RADARS System, Denver, Colorado Professor, University

More information

AHLA. X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion

AHLA. X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion Fraud and Compliance Forum, October 2017. Click here to access audio. AHLA X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion Michelle Bergholz Frazier Senior Vice President,

More information

Today s Presenters. Pills, Providers, and Problems: How to Investigate Drug Diversion in Long-Term Care

Today s Presenters. Pills, Providers, and Problems: How to Investigate Drug Diversion in Long-Term Care Pills, Providers, and Problems: How to Investigate Drug Diversion in Long-Term Care 203 - Monday, April 16, 2018 Today s Presenters Ben Purser Former F.B.I. Special Agent Donna Thiel ProviderTrust Chief

More information

ACCG Mental Health Summit

ACCG Mental Health Summit ACCG Mental Health Summit Sheila Pierce, Opioid Program Coordinator Director, Prescription Drug Management Program Discussion 1. Overview Opioid Problem in GA - Video 2. DPH Opioid Program 3. Priorities

More information

Naloxone and Combating the Opioid Epidemic

Naloxone and Combating the Opioid Epidemic Objectives Naloxone and Combating the Opioid Epidemic Jeff Jacobson PharmD Southpointe Pharmacy Discuss the current opioid crisis Define the role of Naloxone in opioid overdose Analyze the barriers to

More information

Wednesday, June 21, Dear Chairmen and Ranking Members:

Wednesday, June 21, Dear Chairmen and Ranking Members: The Honorable Rodney Frelinghuysen Committee on Appropriations 2306 Rayburn House Office Building The Honorable Tom Cole Subcommittee on Labor, Health and Human Services, Education and Related Agencies

More information

September 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201

September 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201 September 1, 2017 The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201 Dear Secretary Price: The National Association of County

More information

Addressing the Opioid Epidemic: Prescribing Opioids for Non-Cancer Pain

Addressing the Opioid Epidemic: Prescribing Opioids for Non-Cancer Pain Addressing the Opioid Epidemic: Prescribing Opioids for Non-Cancer Pain Ajay D. Wasan, MD, MSc Professor of Anesthesiology and Psychiatry Vice Chair for Pain Medicine, Department of Anesthesiology University

More information

Breakthrough Cancer Pain (BTCP) 25 Years of Study: Key Insights

Breakthrough Cancer Pain (BTCP) 25 Years of Study: Key Insights Breakthrough Cancer Pain (BTCP) 25 Years of Study: Key Insights Steven Wong, MD Assistant Professor of Medicine, Department of Medicine, Division of Hematology/Oncology, UCLA David Geffen School of Medicine

More information

On December 27, 2017, the Lieutenant Governor signed into law several new requirements

On December 27, 2017, the Lieutenant Governor signed into law several new requirements OPIOID Alert MICHIGAN OSTEOPATHIC ASSOCIATION JANUARY 2018 On December 27, 2017, the Lieutenant Governor signed into law several new requirements aimed at combating the opioid epidemic. On the following

More information

Evaluation of the N.C. Prescription

Evaluation of the N.C. Prescription Evaluation of the N.C. Prescription Drug Monitoring Program 2013 National Meeting of the Safe States Alliance and SAVIR MarianaGarrettson Garrettson, MPH Chris Ringwalt, DrPH UNC Injury Prevention Research

More information

OPIOIDS: THE GOOD, THE BAD, AND EVERYTHING IN-BETWEEN

OPIOIDS: THE GOOD, THE BAD, AND EVERYTHING IN-BETWEEN OPIOIDS: THE GOOD, THE BAD, AND EVERYTHING IN-BETWEEN ANTOINETTE BROWN, RPH LAUREL RAMER, 2019 PHARMD CANDIDATE 2018 WYOMING CONFERENCE ON AGING LARAMIE, WY OCTOBER 3, 2018 OBJECTIVES 1. Understand the

More information

Oregon ACEP Opioid Prescribing Guidelines. Why are we talking about this?

Oregon ACEP Opioid Prescribing Guidelines. Why are we talking about this? Oregon ACEP Opioid Prescribing Guidelines Hans Notenboom, M.D. FACEP Current OCEP President Why are we talking about this? Current opioid epidemic 33,000 deaths over half with Rx meds Since 1999 number

More information

North Dakota Board of Pharmacy

North Dakota Board of Pharmacy North Dakota Board of Pharmacy Updates on Drug Abuse Trends, the PDMP and Medical Marijuana Mark J. Hardy, Pharm D Executive Director Disclosure Statement I have no conflict of interests to report Objectives

More information

ADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians

ADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians ADDRESSING THE OPIOID EPIDEMIC Joint principles of the following organizations representing front-line physicians American Academy of Family Physicians American Academy of Pediatrics American College of

More information

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015.

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Louisiana Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

THE PROS & CONS OF THE CDC GUIDELINES FOR SAFE OPIOID PRESCRIBING

THE PROS & CONS OF THE CDC GUIDELINES FOR SAFE OPIOID PRESCRIBING THE PROS & CONS OF THE CDC GUIDELINES FOR SAFE OPIOID PRESCRIBING Ernest J Dole, PharmD, PhC, FASHP, BCPS Clinical Pharmacist University of New Mexico Hospitals And Clinical Associate Professor University

More information